Caspase-1 Proteolytic Activation
Caspase-1 is an inflammatory cysteine protease activated within inflammasomes that cleaves pro-inflammatory cytokines IL-1β and IL-18 and executes pyroptosis via gasdermin D.
Caspase-1, initially cloned and characterized in 1992 as Interleukin-1β Converting Enzyme (ICE), is the prototypical member of the inflammatory caspase family. Unlike apoptotic caspases (such as caspase-3, caspase-8, and caspase-9) that coordinate non-inflammatory programmed cell death, caspase-1 operates at the nexus of innate immunity and inflammation. In response to infection or tissue trauma, cytosolic pattern recognition receptors assemble macromolecular inflammasome complexes that recruit and activate inactive pro-caspase-1 zymogens.
Upon catalytic maturation, active caspase-1 performs three primary physiological tasks: processing immature pro-interleukin-1β (pro-IL-1β) into its biologically active cytokine, cleaving pro-interleukin-18 (pro-IL-18) to stimulate interferon-γ production, and cleaving the pore-forming protein gasdermin D to trigger lytic, inflammatory pyroptosis.
Structural Organization and Zymogen Latency
Caspase-1 is synthesized constitutively as an inactive 45 kDa pro-enzyme (pro-caspase-1) consisting of three distinct structural domains:
- Amino-Terminal CARD Domain (~10 kDa): Mediates homotypic recruitment to upstream inflammasome adaptors.
- Large Catalytic Subunit p20 (~20 kDa): Contains the catalytic active-site cysteine residue (Cys285).
- Small Catalytic Subunit p10 (~10 kDa): Contributes critical substrate-binding loop structures to form the active catalytic cleft.
These domains are separated by flexible peptide linkers containing specific aspartic acid recognition sequences that undergo autocatalytic cleavage during activation.
The Mechanism of Inflammasome-Mediated Dimerization
Pro-caspase-1 monomers reside in the cytosol at nanomolar concentrations, well below the intrinsic dimerization threshold. Activation requires proximity-induced dimerization on the scaffold of an assembled inflammasome:
Upstream Sensor (NLRP3 / NLRC4 / AIM2) → ASC Filament Nucleation → CARD-CARD Assembly of Pro-Caspase-1
Clustering of pro-caspase-1 CARD domains on the ASC speck increases local enzyme concentration, forcing pro-caspase-1 monomers into active homodimers. Dimerization induces allosteric reorganization of the active-site loops, forming two functional catalytic pockets per homodimer before any peptide bond cleavage occurs.
Autoproteolytic Processing Cascade
Once dimerized, caspase-1 executes a sequential, multi-step autoproteolytic processing cascade that governs its substrate specificity and enzymatic lifespan:
| Cleavage Event | Target Peptide Site | Resulting Enzyme Species | Catalytic Activity & Function |
|---|---|---|---|
| Step 1: Linker Cleavage | Between p20 and p10 (Asp297 / Asp316) | Transient p35/p10 Intermediate | Possesses high catalytic activity; efficiently cleaves gasdermin D to initiate pyroptosis |
| Step 2: Prodomain Cleavage | Between CARD and p20 (Asp103 / Asp119) | Soluble Heterotetramer (p20)2(p10)2 | Releases catalytic core from inflammasome; processes pro-IL-1β and pro-IL-18 |
| Step 3: Terminal Inactivation | Secondary internal autolysis | Inactive p20 and p10 fragments | Irreversible catalytic inactivation; limits duration of systemic inflammation |
Crystallographic structures demonstrate that the fully processed enzyme exists as an active heterotetramer composed of two p20 and two p10 subunits [(p20)2(p10)2], featuring two symmetrical active sites each containing the catalytic Cys285-His237 dyad.
Downstream Substrates and Pyroptotic Execution
Active caspase-1 exhibits stringent substrate specificity, recognizing a four-amino-acid peptide motif with an absolute requirement for an aspartic acid residue at the P1 cleavage position [cleaving the consensus sequence Tyr-Val-Ala-Asp-|-Gly (YVAD)].
Processing of Pro-IL-1β and Pro-IL-18
Pro-IL-1β and pro-IL-18 are synthesized as biologically inactive precursors lacking signal peptides:
- Caspase-1 cleaves human pro-IL-1β at Asp116, releasing the 17 kDa mature cytokine that binds the IL-1 receptor (IL-1R) to induce fever, neutrophil recruitment, and acute-phase hepatic protein synthesis.
- Caspase-1 cleaves pro-IL-18 at Asp36, liberating mature IL-18 that synergizes with IL-12 to stimulate natural killer (NK) cells and T lymphocytes to produce interferon-γ (IFN-γ).
Execution of Pyroptosis via Gasdermin D
In 2015, investigations identified gasdermin D (GSDMD) as the critical downstream executioner of caspase-1. Caspase-1 cleaves GSDMD at Asp275 in the central linker, releasing the cytotoxic amino-terminal domain (GSDMD-NT). GSDMD-NT oligomerizes within the inner leaflet of the plasma membrane, punching ~20 nanometer pores that drive cell swelling, osmotic lysis, and the rapid release of mature IL-1β and intracellular alarmins.
Clinical Relevance and Therapeutic Inhibition
Because unrestrained caspase-1 activation underlies severe human inflammatory pathologies, the enzyme serves as a prime therapeutic target:
- Cryopyrin-Associated Periodic Syndromes (CAPS): Gain-of-function NLRP3 mutations drive constitutive caspase-1 activation, resulting in recurrent fevers, sensorineural deafness, and systemic amyloidosis.
- Sepsis and Septic Shock: Uncontrolled caspase-1-driven pyroptosis leads to widespread endothelial necrosis, vascular leakage, and multi-organ failure.
Pharmacological approaches include peptide-mimetic irreversible inhibitors (such as VX-765 / belnacasan) that covalently modify the catalytic Cys285 residue, suppressing cytokine maturation and tissue pathology in preclinical autoimmune models.
References
- Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., ... & Tocci, M. J. (1992). A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature, 356(6372), 768-774.
- Cerretti, D. P., Kozlosky, C. J., Mosley, B., Nelson, N., Ness, K., Greenstreet, T. A., ... & Black, R. A. (1992). Molecular cloning of the interleukin-1 beta converting enzyme. Science, 256(5053), 97-100.
- Broz, P., & Dixit, V. M. (2016). Inflammasomes: mechanism of assembly, regulation and signalling. Nature Reviews Immunology, 16(7), 407-420.